Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Nasal CPAP on Myocardial Dysfunction and Glycemic Control in Patients With Type 2 Diabetes, Obstructive Sleep Apnea and Obesity

NCT03221205 is registered in ClinicalTrials.gov with Instituto Nacional de Enfermedades Respiratorias as lead sponsor.

NCT NCT03221205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03221205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Nasal CPAP on Myocardial Dysfunction and Glycemic Control in Patients With Type 2 Diabetes, Obstructive Sleep Apnea and Obesity
Lead sponsor
Instituto Nacional de Enfermedades Respiratorias
Phase
Not applicable
Overall status
Completed
Start date
October 15, 2014
Completion date
November 24, 2017
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

continuous positive airway pressure, diabetes mellitus, type 2, echocardiography, myocardial dysfunction, obesity, sleep apnea, obstructive